Literature DB >> 27394443

Neuroprotective Effect of Osthole on Neuron Synapses in an Alzheimer's Disease Cell Model via Upregulation of MicroRNA-9.

Shaoheng Li1, Yuhui Yan1, Yanan Jiao1, Zhong Gao2, Yang Xia3, Liang Kong1, Yingjia Yao1, Zhenyu Tao1, Jie Song1, Yaping Yan4, Guangxian Zhang4, Jingxian Yang5.   

Abstract

Accumulation of β-amyloid peptide (Aβ) in the brain plays an important role in the pathogenesis of Alzheimer's disease (AD). It has been reported that osthole exerts its neuroprotective effect on neuronal synapses, but its exact mechanism is obscure. Recently, microRNAs have been demonstrated to play a crucial role in inducing synaptotoxicity by Aβ, implying that targeting microRNAs could be a therapeutic approach of AD. In the present study, we investigated the neuroprotective effects of osthole on a cell model of AD by transducing APP695 Swedish mutant (APP695swe, APP) into mouse cortical neurons and human SH-SY5Y cells. In this study, the cell counting kit CCK-8, apoptosis assay, immunofluorescence analysis, enzyme-linked immunosorbent assay (ELISA), quantitative real-time polymerase chain reaction, and Western blot assay were used. We found that osthole could enhance cell viability, prevent cell death, and reverse the reduction of synaptic proteins (synapsin-1, synaptophysin, and postsynaptic density-95) in APP-overexpressed cells, which was attributed to increases in microRNA-9 (miR-9) expression and subsequent decreases in CAMKK2 and p-AMPKα expressions. These results demonstrated that osthole plays a neuroprotective activity role in part through upregulating miR-9 in AD.

Entities:  

Keywords:  Alzheimer’s disease; Amyloid precursor protein; CAMKK2–AMPK pathway; Neuron synapses; Osthole; miR-9

Mesh:

Substances:

Year:  2016        PMID: 27394443     DOI: 10.1007/s12031-016-0793-9

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  63 in total

Review 1.  MicroRNAs in Alzheimer's disease.

Authors:  Charlotte Delay; Wim Mandemakers; Sébastien S Hébert
Journal:  Neurobiol Dis       Date:  2012-01-17       Impact factor: 5.996

2.  The regulation of AMP-activated protein kinase by phosphorylation.

Authors:  S C Stein; A Woods; N A Jones; M D Davison; D Carling
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

3.  Expression of amyloid-associated miRNAs in both the forebrain cortex and hippocampus of middle-aged rat.

Authors:  Hui Che; Li-Hua Sun; Fei Guo; Hui-Fang Niu; Xiao-Lin Su; Ya-Nan Bao; Zidong Donna Fu; Huai-Lei Liu; Xu Hou; Bao-Feng Yang; Jing Ai
Journal:  Cell Physiol Biochem       Date:  2014-01-02

4.  Identification of microRNAs involved in Alzheimer's progression using a rabbit model of the disease.

Authors:  Qing Yan Liu; Marilyn N Vera Chang; Joy X Lei; Roger Koukiekolo; Brandon Smith; Dongling Zhang; Othman Ghribi
Journal:  Am J Neurodegener Dis       Date:  2014-03-28

5.  Phosphorylation of actin-depolymerizing factor/cofilin by LIM-kinase mediates amyloid beta-induced degeneration: a potential mechanism of neuronal dystrophy in Alzheimer's disease.

Authors:  Lorena Heredia; Pablo Helguera; Soledad de Olmos; Gabriela Kedikian; Francisco Solá Vigo; Frank LaFerla; Matthias Staufenbiel; José de Olmos; Jorge Busciglio; Alfredo Cáceres; Alfredo Lorenzo
Journal:  J Neurosci       Date:  2006-06-14       Impact factor: 6.167

6.  The CAMKK2-AMPK kinase pathway mediates the synaptotoxic effects of Aβ oligomers through Tau phosphorylation.

Authors:  Georges Mairet-Coello; Julien Courchet; Simon Pieraut; Virginie Courchet; Anton Maximov; Franck Polleux
Journal:  Neuron       Date:  2013-04-10       Impact factor: 17.173

7.  MicroRNAs modulate hematopoietic lineage differentiation.

Authors:  Chang-Zheng Chen; Ling Li; Harvey F Lodish; David P Bartel
Journal:  Science       Date:  2003-12-04       Impact factor: 47.728

8.  Neuronal microRNA deregulation in response to Alzheimer's disease amyloid-beta.

Authors:  Nicole Schonrock; Yazi D Ke; David Humphreys; Matthias Staufenbiel; Lars M Ittner; Thomas Preiss; Jürgen Götz
Journal:  PLoS One       Date:  2010-06-11       Impact factor: 3.240

9.  Neurotrophin 3 transduction augments remyelinating and immunomodulatory capacity of neural stem cells.

Authors:  Jingxian Yang; Yaping Yan; Yang Xia; Tingguo Kang; Xing Li; Bogoljub Ciric; Hui Xu; Abdolmohamad Rostami; Guang-Xian Zhang
Journal:  Mol Ther       Date:  2013-10-17       Impact factor: 11.454

10.  NF-kappaB P50/P65 hetero-dimer mediates differential regulation of CD166/ALCAM expression via interaction with micoRNA-9 after serum deprivation, providing evidence for a novel negative auto-regulatory loop.

Authors:  Jiayi Wang; Zhidong Gu; Peihua Ni; Yongxia Qiao; Changqiang Chen; Xiangfan Liu; Jiafei Lin; Ning Chen; Qishi Fan
Journal:  Nucleic Acids Res       Date:  2011-05-13       Impact factor: 16.971

View more
  12 in total

Review 1.  The Role of Synapsins in Neurological Disorders.

Authors:  Fatima Javed Mirza; Saadia Zahid
Journal:  Neurosci Bull       Date:  2017-12-27       Impact factor: 5.203

Review 2.  Targeting Novel microRNAs in Developing Novel Alzheimer's Disease Treatments.

Authors:  Fatemehsadat Seyedaghamiri; Mojgan Rajabi; Gisou Mohaddes
Journal:  Neurochem Res       Date:  2022-09-01       Impact factor: 4.414

3.  A Synthetic Snake-Venom-Based Tripeptide Protects PC12 Cells from the Neurotoxicity of Acrolein by Improving Axonal Plasticity and Bioenergetics.

Authors:  Carolina P Bernardes; Neife A G Santos; Tassia R Costa; Flavia Sisti; Lilian Amaral; Danilo L Menaldo; Martin K Amstalden; Diego L Ribeiro; Lusânia M G Antunes; Suely Vilela Sampaio; Antonio C Santos
Journal:  Neurotox Res       Date:  2019-10-25       Impact factor: 3.911

4.  Mechanism underlying the effects of doxepin on β-amyloid -induced memory impairment in rats.

Authors:  Jimei Bu; Hengbing Zu
Journal:  Iran J Basic Med Sci       Date:  2017-09       Impact factor: 2.699

5.  Osthole Stimulated Neural Stem Cells Differentiation into Neurons in an Alzheimer's Disease Cell Model via Upregulation of MicroRNA-9 and Rescued the Functional Impairment of Hippocampal Neurons in APP/PS1 Transgenic Mice.

Authors:  Shao-Heng Li; Peng Gao; Li-Tong Wang; Yu-Hui Yan; Yang Xia; Jie Song; Hong-Yan Li; Jing-Xian Yang
Journal:  Front Neurosci       Date:  2017-06-13       Impact factor: 4.677

6.  The Aerobic and Cognitive Exercise Study (ACES) for Community-Dwelling Older Adults With or At-Risk for Mild Cognitive Impairment (MCI): Neuropsychological, Neurobiological and Neuroimaging Outcomes of a Randomized Clinical Trial.

Authors:  Cay Anderson-Hanley; Nicole M Barcelos; Earl A Zimmerman; Robert W Gillen; Mina Dunnam; Brian D Cohen; Vadim Yerokhin; Kenneth E Miller; David J Hayes; Paul J Arciero; Molly Maloney; Arthur F Kramer
Journal:  Front Aging Neurosci       Date:  2018-05-04       Impact factor: 5.750

Review 7.  Personalizing the Care and Treatment of Alzheimer's Disease: An Overview.

Authors:  Dubravka Svob Strac; Marcela Konjevod; Marina Sagud; Matea Nikolac Perkovic; Gordana Nedic Erjavec; Barbara Vuic; Goran Simic; Vana Vukic; Ninoslav Mimica; Nela Pivac
Journal:  Pharmgenomics Pers Med       Date:  2021-05-28

Review 8.  Modulation of MicroRNAs as a Potential Molecular Mechanism Involved in the Beneficial Actions of Physical Exercise in Alzheimer Disease.

Authors:  Alex Cleber Improta-Caria; Carolina Kymie Vasques Nonaka; Bruno Raphael Ribeiro Cavalcante; Ricardo Augusto Leoni De Sousa; Roque Aras Júnior; Bruno Solano de Freitas Souza
Journal:  Int J Mol Sci       Date:  2020-07-14       Impact factor: 5.923

Review 9.  The Potential Markers of Circulating microRNAs and long non-coding RNAs in Alzheimer's Disease.

Authors:  Yanfang Zhao; Yuan Zhang; Lei Zhang; Yanhan Dong; Hongfang Ji; Liang Shen
Journal:  Aging Dis       Date:  2019-12-01       Impact factor: 6.745

Review 10.  Precision Medicine in Neurodegenerative Diseases: Some Promising Tips Coming from the microRNAs' World.

Authors:  Nicoletta Nuzziello; Loredana Ciaccia; Maria Liguori
Journal:  Cells       Date:  2019-12-27       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.